BUNKA CHRISTOPHER bought LEXX
July 29, 2025 · Form 4 insider transaction
BUNKA CHRISTOPHER bought 15,600 shares of Lexaria Bioscience Corp. at $0.92 per share, a transaction worth $14.4K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
15,600
Price
$0.92
Total value
$14.4K
InsiderBUNKA CHRISTOPHER
Role—
Securitycommon shares
Transaction codeP: Open-market purchase
Transaction dateJuly 29, 2025
Filing dateJuly 30, 2025
Shares owned after270,012
OwnershipIndirect
10b5-1 planNo
AmendedNo